These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11605176)
1. European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer. Novello S; Le Chevalier T Semin Oncol; 2001 Aug; 28(4 Suppl 14):3-9. PubMed ID: 11605176 [TBL] [Abstract][Full Text] [Related]
2. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions. Bunn PA Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142 [TBL] [Abstract][Full Text] [Related]
3. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer. Belani CP Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783 [TBL] [Abstract][Full Text] [Related]
4. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report. Bonomi P; Faber LP; Recine D; Lincoln S Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927 [TBL] [Abstract][Full Text] [Related]
6. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129 [TBL] [Abstract][Full Text] [Related]
7. High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer. Socinski MA; Shea TC Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-45-S12-51. PubMed ID: 9331121 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy. Hainsworth JD; Greco FA Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970 [TBL] [Abstract][Full Text] [Related]
9. The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer. Bunn PA Semin Oncol; 1996 Dec; 23(6 Suppl 16):18-25. PubMed ID: 9007116 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer. Aisner J; Belani CP; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin MJ Semin Oncol; 1995 Oct; 22(5 Suppl 12):17-21. PubMed ID: 7481856 [TBL] [Abstract][Full Text] [Related]
11. One-hour paclitaxel in the treatment of non-small cell lung cancer. Hainsworth JD; Greco FA Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133 [TBL] [Abstract][Full Text] [Related]
12. Combination paclitaxel and platinum in the treatment of lung cancer: US experience. Bunn PA Semin Oncol; 1996 Dec; 23(6 Suppl 15):9-15. PubMed ID: 8996590 [TBL] [Abstract][Full Text] [Related]
13. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial. Socinski MA; Clark JA; Halle J; Steagall A; Kaluzny B; Rosenman JG Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer. Splinter TA Semin Oncol; 1996 Dec; 23(6 Suppl 16):59-61. PubMed ID: 9007124 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies. Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131 [TBL] [Abstract][Full Text] [Related]
16. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer. Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138 [TBL] [Abstract][Full Text] [Related]
17. Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer. Rosell R; Felip E Semin Oncol; 2001 Aug; 28(4 Suppl 14):37-44. PubMed ID: 11605182 [TBL] [Abstract][Full Text] [Related]
18. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer. Hainsworth JD; Greco FA Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785 [TBL] [Abstract][Full Text] [Related]
19. Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer. Choy H; DeVore RF; Hande KR; Porter LL; Rosenblatt P; Yunus F; Schlabach L; Smith C; Shyr Y; LaPorte K; Johnson DH Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-21-S12-26. PubMed ID: 9331115 [TBL] [Abstract][Full Text] [Related]
20. Platinum drugs in the treatment of non-small-cell lung cancer. Cosaert J; Quoix E Br J Cancer; 2002 Oct; 87(8):825-33. PubMed ID: 12373594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]